Bühler, M. M., Lu, J., Scheinost, S., Nadeu, F., Roos-Weil, D., Hensel, M., . . . Zenz, T. (2021). SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues. Leukemia research, 107, . https://doi.org/10.1016/j.leukres.2021.106608
Chicago-Zitierstil (17. Ausg.)Bühler, Marco Matteo, et al. "SAMHD1 Mutations in Mantle Cell Lymphoma Are Recurrent and Confer in Vitro Resistance to Nucleoside Analogues." Leukemia Research 107 (2021). https://doi.org/10.1016/j.leukres.2021.106608.
MLA-Zitierstil (9. Ausg.)Bühler, Marco Matteo, et al. "SAMHD1 Mutations in Mantle Cell Lymphoma Are Recurrent and Confer in Vitro Resistance to Nucleoside Analogues." Leukemia Research, vol. 107, 2021, https://doi.org/10.1016/j.leukres.2021.106608.